Skip to main content
. 2017 Dec 21;25(1):109–117. doi: 10.1177/1526602817745565

Figure 2.

Figure 2.

Kaplan-Meier estimates of (A) primary patency and (B) clinically-driven target lesion revascularization (TLR) at 12 months. Bars represent the 95% confidence intervals. DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty Number at risk represents the number of evaluable subjects at the beginning of the 30-day window prior to each follow-up interval.